MCG clinical study was presented at ESC Acute Cardiovascular Care 2018 in March 3rd, in Milan, Italy.
This study was conducted in Myanmar, where the locations of the cath-lab are very limited. MCG was compared with CAG, and it showed high sensitivity and specificity for the presence of severe CAD by CAG (≥ 75%).
By Author, it is evaluated as “MCG could be used for prompt detection
of severe CAD in order to start appropriate (PCI/Optimal Medical
Therapy) treatments in the emerging country such as Myanmar where less
medical facilities and skills are available.”
This study was conducted in Myanmar, where the locations of the cath-lab are very limited. MCG was compared with CAG, and it showed high sensitivity and specificity for the presence of severe CAD by CAG (≥ 75%).

Comments
Post a Comment